{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T22:30:29Z","timestamp":1791325829514,"version":"4.3.1"},"reference-count":37,"publisher":"Public Library of Science (PLoS)","issue":"12","license":[{"start":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T00:00:00Z","timestamp":1764720000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010665","name":"H2020 Marie Sk\u0142odowska-Curie Actions","doi-asserted-by":"publisher","award":["713660"],"award-info":[{"award-number":["713660"]}],"id":[{"id":"10.13039\/100010665","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"<jats:sec id=\"sec001\">\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Tuberculosis (TB) remains one of the most globally impactful infectious diseases, with a recorded mortality of 1.6 million in 2022. In Romania and Ukraine, two high burden countries in the context of the WHO European region, treatment is geared towards cure; however, this path is paved with significant challenges, from morbidity to loss to follow-up.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec002\">\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A retrospective study was performed for drug-susceptible TB patients hospitalised in three TB expertise centres in Romania and Ukraine using routinely collected data. Univariable and multivariable logistic regression analyses were used to assess predictors of three treatment outcomes: unfavourable outcomes, loss to follow-up, and death.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec003\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 838 patients diagnosed with drug-susceptible TB were included. Median hospitalisation was 39 days (IQR 25\u201367), and treatment duration was 7 months (IQR 6\u20138). Predictive variables differed by outcome. For unfavourable outcomes, the multivariable model included age\u2009&gt;\u200965 years, chronic kidney disease, at least one cavity on chest X-ray, underweight status, and persistently abnormal laboratory parameters despite intervention. Independent predictors of loss to follow-up were alcohol use, COPD, TB infection within two years prior to admission, obesity, slow treatment response, and sputum microscopy \u22652\u2009+\u2009. Predictors of death included age\u2009&gt;\u200965 years, male sex, cirrhosis, chronic kidney disease, underweight status, persistently abnormal laboratory parameters, and slow treatment response.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec004\">\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Contextualising factors influencing drug-susceptible TB treatment outcomes in different settings can support the development of tailored interventions that enable early identification of patients at higher risk, thereby avoiding unnecessary treatment effects.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1371\/journal.pone.0337937","type":"journal-article","created":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T18:32:13Z","timestamp":1764786733000},"page":"e0337937","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":1,"title":["Factors influencing drug-susceptible tuberculosis treatment outcomes in Romania and Ukraine"],"prefix":"10.1371","volume":"20","author":[{"given":"Ioana","family":"Margineanu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fajri","family":"Gafar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teodora","family":"Butnaru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dragos","family":"Baiceanu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raluca","family":"Dragomir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ihor","family":"Semianiv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florin","family":"Mihaltan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7986-8731","authenticated-orcid":true,"given":"Ioana","family":"Munteanu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatrice","family":"Mahler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liliia","family":"Todoriko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sorina","family":"Margineanu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ymkje","family":"Stienstra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan-Willem C.","family":"Alffenaar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5638-9260","authenticated-orcid":true,"given":"Onno W.","family":"Akkerman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2025,12,3]]},"reference":[{"key":"pone.0337937.ref001","volume-title":"Global tuberculosis report 2022","author":"World Health Organization"},{"issue":"3","key":"pone.0337937.ref002","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2020-044687","article-title":"Systematic review of prediction models for pulmonary tuberculosis treatment outcomes in adults","volume":"11","author":"LS Peetluk","year":"2021","journal-title":"BMJ Open"},{"key":"pone.0337937.ref003","volume-title":"People-centred framework for tuberculosis programme planning and prioritization","author":"World Health Organization","year":"2019"},{"key":"pone.0337937.ref004","author":"European Observatory on Health Systems and Policies","year":"2019"},{"key":"pone.0337937.ref005","author":"European Centre for Disease Prevention and Control"},{"key":"pone.0337937.ref006","author":"\u0426\u0435\u043d\u0442\u0440 \u0433\u0440\u043e\u043c\u0430\u0434\u0441\u044c\u043a\u043e\u0433\u043e \u0437\u0434\u043e\u0440\u043e\u0432\u2019\u044f [Public Health Center]"},{"key":"pone.0337937.ref007","year":"2022"},{"key":"pone.0337937.ref008","author":"World Health Organization"},{"issue":"3","key":"pone.0337937.ref009","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.pulmoe.2020.12.016","article-title":"Tuberculosis, COVID-19 and hospital admission: Consensus on pros and cons based on a review of the evidence","volume":"27","author":"GB Migliori","year":"2021","journal-title":"Pulmonology"},{"key":"pone.0337937.ref010","doi-asserted-by":"crossref","first-page":"439","DOI":"10.2147\/TCRM.S347748","article-title":"Tuberculosis Surveillance in Romania Among Vulnerable Risk Groups Between 2015 and 2017","volume":"18","author":"I Munteanu","year":"2022","journal-title":"Ther Clin Risk Manag"},{"key":"pone.0337937.ref011","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.12688\/f1000research.12687.1","article-title":"Patient predictors of poor drug sensitive tuberculosis treatment outcomes in Kyiv Oblast, Ukraine","volume":"6","author":"O Aibana","year":"2017","journal-title":"F1000Res"},{"key":"pone.0337937.ref012","author":"European Centre for Disease Prevention and Control"},{"key":"pone.0337937.ref013","author":"Urbistat"},{"key":"pone.0337937.ref014","author":"European Commission"},{"key":"pone.0337937.ref015"},{"key":"pone.0337937.ref016","author":"Health Organization W"},{"issue":"4","key":"pone.0337937.ref017","doi-asserted-by":"crossref","first-page":"184","DOI":"10.4103\/2229-3485.167099","article-title":"Elderly patients\u2019 participation in clinical trials","volume":"6","author":"P Shenoy","year":"2015","journal-title":"Perspect Clin Res"},{"key":"pone.0337937.ref018","doi-asserted-by":"crossref","first-page":"152607","DOI":"10.1016\/j.semarthrit.2024.152607","article-title":"The operational definition of old age and impact on outcomes in DMARD-treated patients with rheumatoid arthritis: A systematic literature review","volume":"71","author":"SPM Truijen","year":"2025","journal-title":"Semin Arthritis Rheum"},{"issue":"3","key":"pone.0337937.ref019","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1002\/bimj.201700067","article-title":"Variable selection - A review and recommendations for the practicing statistician","volume":"60","author":"G Heinze","year":"2018","journal-title":"Biom J"},{"issue":"1","key":"pone.0337937.ref020","article-title":"Variable selection strategies and its importance in clinical prediction modelling","volume":"8","author":"MZI Chowdhury","year":"2020","journal-title":"Fam Med Community Health"},{"key":"pone.0337937.ref021","volume-title":"WHO consolidated guidelines on tuberculosis: module 4: treatment: drug-susceptible tuberculosis treatment","author":"World Health Organization","year":"2022"},{"key":"pone.0337937.ref022","author":"European Centre for Disease Prevention and Control"},{"key":"pone.0337937.ref023","doi-asserted-by":"crossref","first-page":"2491","DOI":"10.2147\/IDR.S354855","article-title":"Comparing the Treatment Outcomes of Tuberculosis Patients in a Private Clinic with a Governmental Health Center in Jimma City, Ethiopia: Retrospective Study","volume":"15","author":"EG Abera","year":"2022","journal-title":"Infect Drug Resist"},{"issue":"1","key":"pone.0337937.ref024","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/s12913-025-12265-z","article-title":"Navigating DR-TB Treatment care: a qualitative exploration of barriers and facilitators to retention in care among people with history of early disengagement from drug-resistant tuberculosis treatment in Johannesburg, South Africa","volume":"25","author":"N Mphothulo","year":"2025","journal-title":"BMC Health Serv Res"},{"issue":"2","key":"pone.0337937.ref025","article-title":"Shortened tuberculosis treatment regimens: what is new?","volume":"46","author":"DR Silva","year":"2020","journal-title":"J Bras Pneumol"},{"issue":"11","key":"pone.0337937.ref026","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0242455","article-title":"Correction: A Prediction Rule to Stratify Mortality Risk of Patients with Pulmonary Tuberculosis","volume":"15","author":"HN Bastos","year":"2020","journal-title":"PLoS One"},{"issue":"1","key":"pone.0337937.ref027","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s12879-018-3632-5","article-title":"Development and validation of a risk score to predict mortality during TB treatment in patients with TB-diabetes comorbidity","volume":"19","author":"DT Nguyen","year":"2019","journal-title":"BMC Infect Dis"},{"key":"pone.0337937.ref028","article-title":"Predictors of retrospective tuberculosis treatment outcomes in selected health institutions in Nigeria","volume":"58","author":"N Eze","year":"2021","journal-title":"Eur Respir J"},{"issue":"8","key":"pone.0337937.ref029","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0073250","article-title":"Predictors of death during tuberculosis treatment in TB\/HIV co-infected patients in Malaysia","volume":"8","author":"I Ismail","year":"2013","journal-title":"PLoS One"},{"issue":"1","key":"pone.0337937.ref030","doi-asserted-by":"crossref","first-page":"12995","DOI":"10.1038\/s41598-019-49439-9","article-title":"Predictors for pulmonary tuberculosis treatment outcome in Denmark 2009-2014","volume":"9","author":"IK Holden","year":"2019","journal-title":"Sci Rep"},{"issue":"8","key":"pone.0337937.ref031","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijid.2010.03.001","article-title":"Treatment interruptions among patients with tuberculosis in Russian TB hospitals","volume":"14","author":"EM Belilovsky","year":"2010","journal-title":"Int J Infect Dis"},{"issue":"1","key":"pone.0337937.ref032","doi-asserted-by":"crossref","DOI":"10.4081\/monaldi.2021.1705","article-title":"Factors associated with loss to follow-up among people with tuberculosis in the country of Georgia: a cohort study","volume":"91","author":"N Adamashvili","year":"2021","journal-title":"Monaldi Arch Chest Dis"},{"key":"pone.0337937.ref033","doi-asserted-by":"crossref","first-page":"1136094","DOI":"10.3389\/fmed.2023.1136094","article-title":"Factors associated with loss to follow-up before and after treatment initiation among patients with tuberculosis: A 5-year observation in China","volume":"10","author":"Y Jiang","year":"2023","journal-title":"Front Med (Lausanne)"},{"key":"pone.0337937.ref034","article-title":"Predictors of defaulting from treatment among patients with tuberculosis","volume":"46","author":"M Abdulrazaq","year":"2015","journal-title":"Eur Respir J"},{"issue":"1","key":"pone.0337937.ref035","doi-asserted-by":"crossref","first-page":"00030","DOI":"10.1183\/23120541.00030-2019","article-title":"Predictors of loss to follow-up of tuberculosis cases under the DOTS programme in Namibia","volume":"6","author":"D Kibuule","year":"2020","journal-title":"ERJ Open Res"},{"issue":"6","key":"pone.0337937.ref036","doi-asserted-by":"crossref","first-page":"483","DOI":"10.5588\/ijtld.22.0188","volume":"26","author":"JWC Alffenaar","year":"2022","journal-title":"Int J Tuberc Lung Dis"},{"key":"pone.0337937.ref037","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.ijid.2023.02.024","article-title":"Mortality, risk factors, and causes of death among people with tuberculosis in Denmark, 1990-2018","volume":"130","author":"AC Nordholm","year":"2023","journal-title":"Int J Infect Dis"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0337937","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T18:32:18Z","timestamp":1764786738000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0337937"}},"subtitle":[],"editor":[{"given":"Frederick","family":"Quinn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2025,12,3]]},"references-count":37,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2025,12,3]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0337937","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,3]]}}}